Overview
Thea Veitonmaki practices practicing medicine in Tampere, Finland.
Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, and Nephrectomy.
She is actively involved in clinical research, co-authoring 18 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Thea Veitonmaki
Is Thea Veitonmaki a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Thea Veitonmaki is classified as an Experienced expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Thea Veitonmaki participate in research or clinical trials?
Yes. Thea Veitonmaki has published 18 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Thea Veitonmaki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- NephrectomyMs. Veitonmaki isExperienced. Learn about Nephrectomy.
- Prostate CancerMs. Veitonmaki isExperienced. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Ms. Veitonmaki isExperienced. Learn about Renal Cell Carcinoma (RCC).